Clinical diagnosis and treatment progress of Sjögren's syndrome related xerophthalmia

doi:10.3877/cma.j.issn.2095-2007.2018.02.006

Abstract

Abstract:

Sj?gren syndrome (SS) is a systemic autoimmune disease. Its main feature is the infiltration of immune cells, the destruction of various exocrine glands, and the system function of the other organs of the body. When the disease involving the eye, can easily lead to dry eye, dry eye, photophobia and ocular discomfort symptoms. At present, the pathogenesis of SS related dry eye is not clear, and there is no unified standard for diagnosis and treatment. It has not yet found a cure for radical cure of this disease. The treatment goals of such diseases are mainly to control the disease, relieve symptoms and reduce complications. In recent years, with the further research of immune system diseases and dry eye treatment, SS related dry eye treatment has made great progress. In this paper, the author focuses on the clinical diagnosis and treatment of SS related dry eye disease, and collate the recent advances in the diagnosis and treatment of such diseases, in order to provide reference for the clinical diagnosis and treatment of SS related dry eye.

Key words: Sj?gren syndrome, Dry eye, Diagnostic criteria

Xin Wang, Su Liu. Clinical diagnosis and treatment progress of Sjögren's syndrome related xerophthalmia[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2018, 08(02): 82-86.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2018.02.006

https://zhykyxzz.cma-cmc.com.cn/EN/Y2018/V08/I02/82

References 52

[1]	Both T, Dalm VA, Hagen PM, et al. Reviewing primary Sjögren's syndrome: beyond the dryness－From pathophysiology to diagnosis and treatment[J]. International Journal of Medical Sciences, 2017, 14(3):191-200.
[2]	Liew MS, Zhang M, Kim E, et al. Prevalence and predictors of Sjögren's syndrome in a prospective cohort of patients with aqueous－deficient dry eye[J]. Br J Ophthalmol, 2012, 96(12):1498-1503.
[3]	Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca[J]. Current Eye Research, 1999, 19(3):201-211.
[4]	Bowman SJ, Ibrahim GH, Holmes G, et al. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK[J]. Acta Rheumatologica Scandinavica, 2004, 33(1):39-43.
[5]	Baimpa E, Dahabreh IJ, Voulgarelis M, et al. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects[J]. Medicine, 2009, 88(5):284-293.
[6]	Valim V, Zandonade E, Pereira AM, et al. Primary Sjögren's syndrome prevalence in a major metropolitan area in Brazil[J]. Revista Brasileira De Reumatologia, 2013, 53(1):24-28.
[7]	Fauchais AL, Martel C, Vidal E. Epidemiology and physiopathogy of Sjögren's syndrome[J]. La Revue Du Praticien, 2012, 62(2):218-220.
[8]	Tsuboi H, Asashima H, Takai C, et al. Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan[J]. Modern Rheumatology, 2014, 24(3):464-470.
[9]	Kim HJ, Kim KH, Hann HJ, et al. Incidence, Mortality and Causes of Death in Physician－Diagnosed Primary Sjögren′s Syndrome in Korea－A Nationwide, Population－Based Study[J]. Semin Arthritis Rheum, 2017，47(2):222-227.
[10]	中华医学会风湿病学分会. 干燥综合征诊断及治疗指南[J]. 中华风湿病学杂志，2010，14(11):766-768.
[11]	袁锁娟，陆雯俊，沈友轩. 原发性干燥综合征93例临床表现[J]. 中国微循环，2009，13(4):316.
[12]	Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man[J]. Journal of Dental Research, 1987, 66(1):648-653.
[13]	Chia E, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study[J]. Clinical Experimental Ophthalmology, 2003, 31(3):229-232.
[14]	Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women[J]. Am J Ophthalmol, 2003, 136(2):318-326.
[15]	杨永明，马林昆. 干眼的流行病学研究进展[J]. 国际眼科杂志，2010，10(10):1944-1946.
[16]	王焕荣，赵乐. 126例干眼病因分析[J]. 中国斜视与小儿眼科杂志，2012，20(3):115-117.
[17]	Karthaus M, Carratalà J, Jürgens H, et al. New Strategies in the Treatment of Infectious Complications in Haematology and Oncology：Is There a Role for Out－Patient Antibiotic Treatment of Febrile Neutropenia？[J]. Chemotherapy, 1998, 44(6):427-435.
[18]	Douillard JY, Gervais R, Dabouis G, et al. Sequential two－line strategy for stage Ⅳ non－small－cell lung cancer: docetaxel－cisplatin versus vinorelbine－cisplatin followed by cross－over to single－agent docetaxel or vinorelbine at progression: final results of a randomised phase Ⅱ study[J]. Annals of Oncology, 2005, 16(1):81-89.
[19]	Maciejewski JP, Ristiano AM, Sloand EM, et al. A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)－Fc fusion protein in patients with myelodysplastic syndrome[J]. British Journal of Haematology, 2002, 117(1):119-126.
[20]	Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adap－tive immune responses are associated with Sjögren's syndrome[J]. Nat Genet, 2013, 45(11):1284-1292.
[21]	Li Y, Zhang K, Chen H, et al. A genome－wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23[J]. Nature Genetics, 2013, 45(11):1361-1365.
[22]	Pontarini E, Lucchesi D, Bombardieri M. Current views on the pathogenesis of Sjögren's syndrome[J]. Current Opinion in Rheumatology, 2018, 30(2):215-221.
[23]	Moriyama M, Hayashida JN, Toyoshima T, et al. Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome[J]. Clinical & Experimental Immunology, 2012, 169(1):17-26.
[24]	Kivity S, Sneh E, Greif J, et al. The effect of food and exercise on the skin response to compound 48/80 in patients with food－associated exercise－induced urticaria－angioedema[J]. Journal of Allergy & Clinical Immunology, 1988, 81(6):1155-1158.
[25]	Kivity S, Arango MT, Ehrenfeld M, et al. Infection and autoimmunity in Sjögren's syndrome: a clinical study and comprehensive review[J]. Journal of Autoimmunity, 2014, 51(2):17-22.
[26]	Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN Pathways and Plasmacytoid Dendritic Cell Recruitment in Target Organs of Primary Sjögren's Syndrome[J]. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(8):2770-2775.
[27]	Ciccia F, Guggino G, Rizzo A, et al. Potential involvement of IL－22 and IL－22－producing cells in the inflamed salivary glands of patients with Sjögren's syndrome[J]. Annals of the Rheumatic Diseases, 2012, 71(2):295-301.
[28]	张昊泽，张奉春. 深入探究干燥综合征的发病机制[J]. 中华内科杂志，2015，54(11):157-158.
[29]	Lemp MA. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)[J]. Ocular Surface, 2007, 5(2):75-92.
[30]	Menzies KL, Srinivasan S, Prokopich CL, et al. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls[J]. Invest Ophthalmol Vis Sci, 2015, 56(2):836-841.
[31]	Amparo F, Schaumberg DA, Dana R. Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye[J]. Ophthalmology, 2015, 122(7):1498-1503.
[32]	Tseng SC. A practical treatment algorithm for managing ocular surface and tear disorders[J]. Cornea, 2011, 30(Suppl. 1):8-14.
[33]	Listed N. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)[J]. Ocular Surface, 2007, 5(2):108-152.
[34]	Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease[J]. Deutsches Ärzteblatt International, 2015, 112(5):71-81.
[35]	陆炯，梁庆丰. 角膜共聚焦显微镜检查辅助治疗干眼症的临床研究[J/CD]. 中华眼科医学杂志(电子版)，2016，6(5):213-218.
[36]	庄宏，徐建江. 常规眼科技术在干眼症检查方面的拓展应用[J]. 中华实验眼科杂志，2009，27(11):1050-1053.
[37]	Jung JH, Ji YW, Hwang HS, et al. Proteomic analysis of human lacrimal and tear fluid in dry eye disease[J]. Sci Rep, 2017, 7(1):13363.
[38]	Potvin R, Makari S, Rapuano CJ. Tear film osmolarity and dry eye disease: a review of the literature[J]. Clinical Ophthalmology, 2015, 9(default):2039-2047.
[39]	Foulks GN, Forstot SL, Donshik PC, et al. Clinical guidelines for management of dry eye associated with Sjögren disease[J]. Ocular Surface, 2015, 13(2):118-132.
[40]	Tsubota K, Fujita H, Tsuzaka K, et al. Quantitative analysis of lacrimal gland function, apoptotic figures, Fas and Fas ligand expression of lacrimal glands in dry eye patients[J]. Experimental Eye Research, 2003, 76(2):233-240.
[41]	Chhadva P, Goldhardt R, Galor A. Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease[J]. Ophthalmology, 2017, 124(11):20-26.
[42]	Wang MT, Jaitley Z, Lord SM, et al. Comparison of Self－applied Heat Therapy for Meibomian Gland Dysfunction[J]. Optomet Vision Sci, 2015, 92(9):321-326.
[43]	Nakamura T, Inatomi T, Sotozono C, et al. Transplantation of autologous serum－derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease[J]. Ophthalmology, 2006, 113(10):1765-1772.
[44]	姜淑华，胡丽伟，孙凤艳，等．中医辨证论治治疗干燥综合征的临床研究[J]．世界最新医学信息文摘，2017，17(50):91-92.
[45]	李影，高卫萍. 干眼症的中医药治疗近况[J]. 山东中医杂志，2010，29(2):139-140.
[46]	Akpek EK, Lindsley KB, Adyanthaya RS, et al. Treatment of Sjögren's syndrome－associated dry eye an evidence－based review[J]. Ophthalmology, 2011, 118(7):1242-1252.
[47]	Chen H, Zhou S, Su D, et al. High－dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren's syndrome patients with thrombocytopenia[J]. Clinical Rheumatology, 2013, 32(12):1783-1790.
[48]	Yacoub YI, Rostom S, Laatiris A, et al. Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life[J]. Rheumatology International, 2012, 32(9):2637-2643.
[49]	文中华，李淑琳，张玉明，等. 原发性干燥综合征干眼的中西医结合治疗临床研究[J]. 眼科新进展，2015，35(12):1166-1169.
[50]	Westhoff G, Dörner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjogren's syndrome: results from a cohort study[J]. Rheumatology, 2012, 51(2):262.
[51]	Strömbeck B, Ekdahl C, Manthorpe R, et al. Health－related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF－36[J]. Acta Rheumatologica Scandinavica, 2000, 29(1):20-28.
[52]	Strand V, Scott DL, Emery P, et al. Physical function and health related quality of life: analysis of 2－year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis[J]. Journal of Rheumatology, 2005, 32(4):590-601.

Please choose a citation manager

Content to export